MDCO Insider Trading Activity and SEC Form 4 Filings
MDCO insider trading summary
No open-market insider purchases or sales of Medicines Co (MDCO) have been reported on SEC Form 4 in the past 12 months.
Latest MDCO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 2, 2019 | Stephen M Rodin | EVP and General Counsel | Sell | $174K (5,000 @ $34.82) |
| Jun 28, 2019 | Alexander J Denner | Director | Buy | $1.6M (50,000 @ $33.00) |
| May 30, 2019 | Alexander J Denner | Director | Buy | $1.7M (50,000 @ $34.81) |
| May 29, 2019 | Alexander J Denner | Director | Buy | $1.2M (35,000 @ $34.85) |
| May 22, 2019 | Alexander J Denner | Director | Buy | $4.6M (139,000 @ $33.13) |
| May 21, 2019 | Alexander J Denner | Director | Buy | $4.5M (132,000 @ $33.95) |
| May 20, 2019 | Alexander J Denner | Director | Buy | $5.5M (160,000 @ $34.50) |
| Mar 6, 2019 | Alexander J Denner | Director | Buy | $6.2M (248,100 @ $24.91) |
| Mar 5, 2019 | Alexander J Denner | Director | Buy | $4.7M (181,900 @ $26.07) |
| Mar 4, 2019 | Alexander J Denner | Director | Buy | $8.3M (325,000 @ $25.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.